Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.72 | 12.12 |
PEG Ratio (TTM) | -0.01 | 1.22 |
P/S Ratio (TTM) | 0.25 | 4.47 |
P/B Ratio (TTM) | 0.49 | 3.46 |
P/FCF Ratio (TTM) | -2.22 | 25.26 |
Price to 5YR AVG Earnings Ratio | N/A | 29.99 |
Price to 5YR AVG FCF Ratio | N/A | 19.55 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -26.94% | 3.23% |
ROE (TTM) | -63.67% | 10.07% |
Net Profit Margin (TTM) | -27.21% | -12.78% |
ROIC 5YR AVG | N/A | 9.34% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 36.10% | 7.21% | N/A |
Revenue | 7.16% | -9.58% | N/A |
Net Income | 14.49% | -22.71% | N/A |
Cash Flow | -109.28% | -14.72% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.69 | 2.46 |
Quick Ratio (TTM) | 2.84 | 1.83 |
D/E Ratio (TTM) | 0.02 | -0.08 |
Interest Coverage (TTM) | N/A | 15.94 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 4.50 |
LTL to 5YR AVG FCF | N/A | 5.16 |
Shares Outstanding Growth 5YR AVG | N/A | 26.19% |